COMMUNIQUÉS West-GlobeNewswire

Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary “Leaky Gut” Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study
12/11/2018
Significant effect on gut epithelial integrity, a mechanism thought to be key for bacterial translocation leading to NAFLD and NASH. Innovate plans to launch a clinical development program for NASH in 2019 Data [...]
Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement
12/11/2018
SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Novan Announces Corporate Update Conference Call and Webcast
12/11/2018
MORRISVILLE, N.C., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, November 14, at 8:30 a.m. Eastern Time [...]
Hospital for Special Care expands and extends relationship with Allscripts; Allscripts Sunrise helps Autism Center and COPD Disease Management programs earn first in nation Patient Centered Specialty Practice recognition for program types
12/11/2018
Not-for-profit hospital extends and further expands portfolio to include integrated registration, scheduling tools and medication management solutions CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX [...]
Matrix Medical Network Recognizes National Nurse Practitioner Week
12/11/2018
SCOTTSDALE, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) is recognizing nurse practitioners nationwide and within our own clinical teams during National Nurse Practitioner Week, November 11- [...]
HTG Molecular Presenting at Upcoming Healthcare Conferences
12/11/2018
TUCSON, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ [...]
Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update
12/11/2018
BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that [...]
Immutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
12/11/2018
SYDNEY, Australia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
PotNetwork Holding's Diamond CBD Presented Chong’s Choice, Showcased at the Las Vegas Convention Center, at the Recent 2018 CBD.io in Collaboration With VAPEXPO Event Held November 9th and 10th
12/11/2018
Company Joined the Biggest Names in Vape and Hemp for an Epic Collaboration of Two Swiftly Growing Industries Fort Lauderdale, Fla., Nov. 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holdings, Inc. (OTC [...]
HempAmericana Commences Processing Hemp Flower at CBD Production Facility
12/11/2018
NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun processing 4,100 lbs of in-house Hemp Flower [...]
Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference
12/11/2018
REDWOOD CITY, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will be presenting at the 27th Annual Credit Suisse Healthcare Conference being [...]
Palvella Therapeutics Announces FDA Fast Track Designation for PTX-022 for Treatment of Pachyonychia Congenita
12/11/2018
Wayne, PA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating genetic [...]
Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call
12/11/2018
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), a highly differentiated cannabis company with major cannabis cultivation and [...]
Transactions under Novozymes’ stock buyback program
12/11/2018
Please read the full announcement in the attached PDF Attachment 2018_63_Stock_Buybackprogram_EN
Apotheca Biosciences (PCFP) Plans Uplisting to OTCQB
12/11/2018
SAINT PETERSBURG, FL, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
Pain Therapeutics Appeals FDA Decision on REMOXY
12/11/2018
AUSTIN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it has petitioned the Food & Drug Administration (FDA) regarding a Complete [...]
MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions
12/11/2018
Improved Left Ventricular Compliance Demonstrated in Genetic Pig Model of Non-Obstructed Hypertrophic Cardiomyopathy Results Add to Growing Body of Evidence of Mavacamten’s Dual Activity in Increasing Compliance and [...]
New Findings from Pluristem’s Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation
12/11/2018
Additional data from Pluristem’s Phase II IC study were presented at the 2018 American Heart Association Scientific Sessions HAIFA, Israel, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) ( [...]
Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones
12/11/2018
VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") has reported its financial and operational results for the three and [...]

Pages